25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

CRMD (Cormedix) Stock Analysis
Buy, Hold or Sell?

Let's analyze Cormedix together

I guess you are interested in CorMedix Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Cormedix’s Financial Insights
  • 📈 Technical Analysis (TA) – Cormedix’s Price Targets

I'm going to help you getting a better view of CorMedix Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about CorMedix Inc

I send you an email if I find something interesting about CorMedix Inc.

1. Quick Overview

1.1. Quick analysis of Cormedix (30 sec.)










1.2. What can you expect buying and holding a share of Cormedix? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2,955.57
Expected worth in 1 year
$5,910.52
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$2,954.95
Return On Investment
25,495.7%

For what price can you sell your share?

Current Price per Share
$11.59
Expected price per share
$9.605 - $17.43
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Cormedix (5 min.)




Live pricePrice per Share (EOD)
$11.59
Intrinsic Value Per Share
$9,713.72 - $39,150.57
Total Value Per Share
$12,669.29 - $42,106.14

2.2. Growth of Cormedix (5 min.)




Is Cormedix growing?

Current yearPrevious yearGrowGrow %
How rich?$220.6b$64.3m$55.1b99.9%

How much money is Cormedix making?

Current yearPrevious yearGrowGrow %
Making money$12.7m-$13.2m$26m203.8%
Net Profit Margin30.4%-1,651.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Cormedix (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#2 / 853

Most Revenue
#182 / 853

Most Profit
#78 / 853
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Cormedix?

Welcome investor! Cormedix's management wants to use your money to grow the business. In return you get a share of Cormedix.

First you should know what it really means to hold a share of Cormedix. And how you can make/lose money.

Speculation

The Price per Share of Cormedix is $11.59. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cormedix.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cormedix, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2,955.57. Based on the TTM, the Book Value Change Per Share is $738.74 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cormedix.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.272.3%0.171.5%-0.18-1.5%-0.04-0.4%-0.06-0.5%-0.08-0.7%
Usd Book Value Change Per Share2,954.0325,487.7%738.746,373.9%-0.01-0.1%246.232,124.5%147.771,274.9%73.88637.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share2,954.0325,487.7%738.746,373.9%-0.01-0.1%246.232,124.5%147.771,274.9%73.88637.4%
Usd Price Per Share12.32-8.67-4.01-5.49-5.74-4.38-
Price to Earnings Ratio11.60--6.48--5.76--6.68--10.94--15.28-
Price-to-Total Gains Ratio0.00-21.67--16.71--50.36--36.22--291.11-
Price to Book Ratio0.00-5.36-4.94-5.20-6.30-9.22-
Price-to-Total Gains Ratio0.00-21.67--16.71--50.36--36.22--291.11-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share11.59
Number of shares86
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share738.74147.77
Usd Total Gains Per Share738.74147.77
Gains per Quarter (86 shares)63,531.4112,707.88
Gains per Year (86 shares)254,125.6350,831.50
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1025412625411605083250822
205082515082420101663101654
307623777623680152495152486
40101650310164940203326203318
50127062812706200254158254150
60152475415247460304989304982
70177887917788720355821355814
80203300520329980406652406646
90228713122871240457484457478
100254125625412500508315508310

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%3.09.00.025.0%3.017.00.015.0%4.036.00.010.0%6.060.01.09.0%
Book Value Change Per Share4.00.00.0100.0%5.07.00.041.7%9.011.00.045.0%13.027.00.032.5%21.043.03.031.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%4.00.063.06.0%
Total Gains per Share4.00.00.0100.0%5.07.00.041.7%9.011.00.045.0%13.027.00.032.5%21.043.03.031.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of CorMedix Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2954.029738.737+300%-0.010+100%246.228+1100%147.766+1899%73.877+3899%
Book Value Per Share--2955.568739.757+300%0.863+342572%247.112+1096%148.595+1889%74.408+3872%
Current Ratio--7.8224.845+61%7.504+4%7.513+4%10.817-28%8.113-4%
Debt To Asset Ratio--0.1270.222-43%0.146-13%0.159-20%0.129-2%0.303-58%
Debt To Equity Ratio--0.1450.293-51%0.173-16%0.164-12%0.125+16%0.408-64%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--159662575680.00040354424297.500+296%355463411.750+44817%13680938671.083+1067%8414747991.350+1797%4327498151.005+3589%
Eps--0.2660.171+55%-0.178+167%-0.043+116%-0.063+124%-0.080+130%
Ev To Ebitda Ratio--1945.293475.828+309%-6.792+100%153.250+1169%84.487+2202%37.219+5127%
Ev To Sales Ratio--1004.501256.614+291%197.158+409%1776.252-43%3897.108-74%2663.920-62%
Free Cash Flow Per Share--665.898166.476+300%-0.171+100%55.400+1102%33.208+1905%16.569+3919%
Free Cash Flow To Equity Per Share--667.013166.860+300%-0.023+100%55.599+1100%33.392+1898%16.698+3895%
Gross Profit Margin---320.973-79.093-75%1.482-21752%-25.513-92%-14.908-95%-6.953-98%
Intrinsic Value_10Y_max--39150.573----------
Intrinsic Value_10Y_min--9713.723----------
Intrinsic Value_1Y_max--758.464----------
Intrinsic Value_1Y_min--221.771----------
Intrinsic Value_3Y_max--4690.745----------
Intrinsic Value_3Y_min--1321.270----------
Intrinsic Value_5Y_max--11530.819----------
Intrinsic Value_5Y_min--3130.123----------
Market Cap865181910.000-6%919675680.000646833585.000+42%299155867.500+207%409605283.750+125%428690544.750+115%327135805.680+181%
Net Profit Margin--0.4990.304+64%-16.518+3410%-110.390+22223%-189.733+38124%-185.782+37332%
Operating Margin--0.5120.308+66%-16.516+3324%-112.084+21980%-199.994+39140%-202.038+39539%
Operating Ratio--0.5080.716-29%17.876-97%115.006-100%201.981-100%201.716-100%
Pb Ratio0.004-6%0.0045.356-100%4.944-100%5.203-100%6.305-100%9.224-100%
Pe Ratio10.909-6%11.596-6.478+156%-5.756+150%-6.676+158%-10.942+194%-15.281+232%
Price Per Share11.590-6%12.3208.665+42%4.008+207%5.487+125%5.743+115%4.382+181%
Price To Free Cash Flow Ratio0.004-6%0.005-8.021+173511%-6.145+132962%-7.829+169357%-12.862+278188%11.515-100%
Price To Total Gains Ratio0.004-6%0.00421.666-100%-16.706+400671%-50.362+1207646%-36.219+868544%-291.108+6980142%
Quick Ratio--6.0164.394+37%9.850-39%9.463-36%12.613-52%10.107-40%
Return On Assets--0.0000.054-100%-0.186+237108%0.525-100%0.271-100%-0.062+79463%
Return On Equity--0.0000.073-100%-0.221+245799%-0.059+66075%-0.071+78959%-0.446+496373%
Total Gains Per Share--2954.029738.737+300%-0.010+100%246.228+1100%147.766+1899%73.877+3899%
Usd Book Value--220630187000.00055222111066.500+300%64385225.500+342572%18446694654.417+1096%11092498143.150+1889%5554477842.075+3872%
Usd Book Value Change Per Share--2954.029738.737+300%-0.010+100%246.228+1100%147.766+1899%73.877+3899%
Usd Book Value Per Share--2955.568739.757+300%0.863+342572%247.112+1096%148.595+1889%74.408+3872%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--159662575680.00040354424297.500+296%355463411.750+44817%13680938671.083+1067%8414747991.350+1797%4327498151.005+3589%
Usd Eps--0.2660.171+55%-0.178+167%-0.043+116%-0.063+124%-0.080+130%
Usd Free Cash Flow--49708590674.00012427258230.500+300%-12798911.250+100%4135541199.083+1102%2478917408.350+1905%1236828255.225+3919%
Usd Free Cash Flow Per Share--665.898166.476+300%-0.171+100%55.400+1102%33.208+1905%16.569+3919%
Usd Free Cash Flow To Equity Per Share--667.013166.860+300%-0.023+100%55.599+1100%33.392+1898%16.698+3895%
Usd Market Cap865181910.000-6%919675680.000646833585.000+42%299155867.500+207%409605283.750+125%428690544.750+115%327135805.680+181%
Usd Price Per Share11.590-6%12.3208.665+42%4.008+207%5.487+125%5.743+115%4.382+181%
Usd Profit--19827981.00012789867.750+55%-13278999.000+167%33550454.083-41%17353333.200+14%5706372.650+247%
Usd Revenue--39736790.00030371124.500+31%277557.250+14217%10219270.500+289%6149990.250+546%3110392.300+1178%
Usd Total Gains Per Share--2954.029738.737+300%-0.010+100%246.228+1100%147.766+1899%73.877+3899%
 EOD+4 -4MRQTTM+31 -7YOY+33 -53Y+30 -85Y+29 -910Y+32 -6

3.3 Fundamental Score

Let's check the fundamental score of CorMedix Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1510.909
Price to Book Ratio (EOD)Between0-10.004
Net Profit Margin (MRQ)Greater than00.499
Operating Margin (MRQ)Greater than00.512
Quick Ratio (MRQ)Greater than16.016
Current Ratio (MRQ)Greater than17.822
Debt to Asset Ratio (MRQ)Less than10.127
Debt to Equity Ratio (MRQ)Less than10.145
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.000
Total8/10 (80.0%)

3.4 Technical Score

Let's check the technical score of CorMedix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose12.590
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Fundamental data was last updated by Penke on 2025-09-03 19:56:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Cormedix earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cormedix to the Biotechnology industry mean.
  • A Net Profit Margin of 49.9% means that $0.50 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of CorMedix Inc:

  • The MRQ is 49.9%. The company is making a huge profit. +2
  • The TTM is 30.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ49.9%TTM30.4%+19.5%
TTM30.4%YOY-1,651.8%+1,682.2%
TTM30.4%5Y-18,973.3%+19,003.7%
5Y-18,973.3%10Y-18,578.2%-395.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ49.9%-85.5%+135.4%
TTM30.4%-168.0%+198.4%
YOY-1,651.8%-210.0%-1,441.8%
3Y-11,039.0%-289.9%-10,749.1%
5Y-18,973.3%-382.7%-18,590.6%
10Y-18,578.2%-520.3%-18,057.9%
4.3.1.2. Return on Assets

Shows how efficient Cormedix is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cormedix to the Biotechnology industry mean.
  • 0.0% Return on Assets means that Cormedix generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of CorMedix Inc:

  • The MRQ is 0.0%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 5.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ0.0%TTM5.4%-5.4%
TTM5.4%YOY-18.6%+24.0%
TTM5.4%5Y27.1%-21.7%
5Y27.1%10Y-6.2%+33.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0%-11.9%+11.9%
TTM5.4%-12.0%+17.4%
YOY-18.6%-11.3%-7.3%
3Y52.5%-12.0%+64.5%
5Y27.1%-11.7%+38.8%
10Y-6.2%-13.8%+7.6%
4.3.1.3. Return on Equity

Shows how efficient Cormedix is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cormedix to the Biotechnology industry mean.
  • 0.0% Return on Equity means Cormedix generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of CorMedix Inc:

  • The MRQ is 0.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 7.3%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.0%TTM7.3%-7.3%
TTM7.3%YOY-22.1%+29.4%
TTM7.3%5Y-7.1%+14.4%
5Y-7.1%10Y-44.6%+37.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0%-14.2%+14.2%
TTM7.3%-15.1%+22.4%
YOY-22.1%-15.1%-7.0%
3Y-5.9%-16.9%+11.0%
5Y-7.1%-17.5%+10.4%
10Y-44.6%-19.7%-24.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of CorMedix Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Cormedix is operating .

  • Measures how much profit Cormedix makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cormedix to the Biotechnology industry mean.
  • An Operating Margin of 51.2% means the company generated $0.51  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of CorMedix Inc:

  • The MRQ is 51.2%. The company is operating very efficient. +2
  • The TTM is 30.8%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ51.2%TTM30.8%+20.5%
TTM30.8%YOY-1,651.6%+1,682.3%
TTM30.8%5Y-19,999.4%+20,030.2%
5Y-19,999.4%10Y-20,203.8%+204.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ51.2%-154.1%+205.3%
TTM30.8%-270.5%+301.3%
YOY-1,651.6%-254.3%-1,397.3%
3Y-11,208.4%-276.4%-10,932.0%
5Y-19,999.4%-350.8%-19,648.6%
10Y-20,203.8%-532.3%-19,671.5%
4.3.2.2. Operating Ratio

Measures how efficient Cormedix is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.51 means that the operating costs are $0.51 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of CorMedix Inc:

  • The MRQ is 0.508. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.716. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.508TTM0.716-0.208
TTM0.716YOY17.876-17.160
TTM0.7165Y201.981-201.264
5Y201.98110Y201.716+0.264
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5081.891-1.383
TTM0.7162.917-2.201
YOY17.8763.080+14.796
3Y115.0063.835+111.171
5Y201.9814.924+197.057
10Y201.7166.864+194.852
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of CorMedix Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Cormedix is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.82 means the company has $7.82 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of CorMedix Inc:

  • The MRQ is 7.822. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.845. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.822TTM4.845+2.978
TTM4.845YOY7.504-2.660
TTM4.8455Y10.817-5.972
5Y10.81710Y8.113+2.703
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.8223.480+4.342
TTM4.8453.795+1.050
YOY7.5044.104+3.400
3Y7.5134.607+2.906
5Y10.8175.762+5.055
10Y8.1136.164+1.949
4.4.3.2. Quick Ratio

Measures if Cormedix is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cormedix to the Biotechnology industry mean.
  • A Quick Ratio of 6.02 means the company can pay off $6.02 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of CorMedix Inc:

  • The MRQ is 6.016. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.394. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.016TTM4.394+1.622
TTM4.394YOY9.850-5.456
TTM4.3945Y12.613-8.219
5Y12.61310Y10.107+2.506
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.0162.952+3.064
TTM4.3943.302+1.092
YOY9.8503.927+5.923
3Y9.4634.393+5.070
5Y12.6135.875+6.738
10Y10.1076.549+3.558
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of CorMedix Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Cormedix assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cormedix to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.13 means that Cormedix assets are financed with 12.7% credit (debt) and the remaining percentage (100% - 12.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of CorMedix Inc:

  • The MRQ is 0.127. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.222. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.127TTM0.222-0.096
TTM0.222YOY0.146+0.077
TTM0.2225Y0.129+0.093
5Y0.12910Y0.303-0.174
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1270.340-0.213
TTM0.2220.355-0.133
YOY0.1460.335-0.189
3Y0.1590.341-0.182
5Y0.1290.349-0.220
10Y0.3030.379-0.076
4.5.4.2. Debt to Equity Ratio

Measures if Cormedix is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cormedix to the Biotechnology industry mean.
  • A Debt to Equity ratio of 14.5% means that company has $0.14 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of CorMedix Inc:

  • The MRQ is 0.145. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.293. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.145TTM0.293-0.148
TTM0.293YOY0.173+0.120
TTM0.2935Y0.125+0.168
5Y0.12510Y0.408-0.283
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1450.393-0.248
TTM0.2930.436-0.143
YOY0.1730.436-0.263
3Y0.1640.461-0.297
5Y0.1250.459-0.334
10Y0.4080.514-0.106
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cormedix generates.

  • Above 15 is considered overpriced but always compare Cormedix to the Biotechnology industry mean.
  • A PE ratio of 11.60 means the investor is paying $11.60 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of CorMedix Inc:

  • The EOD is 10.909. Based on the earnings, the company is underpriced. +1
  • The MRQ is 11.596. Based on the earnings, the company is underpriced. +1
  • The TTM is -6.478. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD10.909MRQ11.596-0.687
MRQ11.596TTM-6.478+18.074
TTM-6.478YOY-5.756-0.723
TTM-6.4785Y-10.942+4.464
5Y-10.94210Y-15.281+4.339
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD10.909-2.537+13.446
MRQ11.596-2.362+13.958
TTM-6.478-2.678-3.800
YOY-5.756-3.833-1.923
3Y-6.676-3.900-2.776
5Y-10.942-6.480-4.462
10Y-15.281-7.170-8.111
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of CorMedix Inc:

  • The EOD is 0.004. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 0.005. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -8.021. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.004MRQ0.0050.000
MRQ0.005TTM-8.021+8.025
TTM-8.021YOY-6.145-1.876
TTM-8.0215Y-12.862+4.842
5Y-12.86210Y11.515-24.377
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.004-3.385+3.389
MRQ0.005-3.040+3.045
TTM-8.021-3.676-4.345
YOY-6.145-4.421-1.724
3Y-7.829-5.258-2.571
5Y-12.862-8.587-4.275
10Y11.515-9.639+21.154
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Cormedix is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.00 means the investor is paying $0.00 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of CorMedix Inc:

  • The EOD is 0.004. Based on the equity, the company is cheap. +2
  • The MRQ is 0.004. Based on the equity, the company is cheap. +2
  • The TTM is 5.356. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD0.004MRQ0.0040.000
MRQ0.004TTM5.356-5.351
TTM5.356YOY4.944+0.412
TTM5.3565Y6.305-0.949
5Y6.30510Y9.224-2.920
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.0042.199-2.195
MRQ0.0041.995-1.991
TTM5.3562.190+3.166
YOY4.9442.415+2.529
3Y5.2032.574+2.629
5Y6.3053.805+2.500
10Y9.2244.462+4.762
4.6.2. Total Gains per Share

2.4. Latest News of CorMedix Inc

Does CorMedix Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from CorMedix Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-09-15
18:42
PBYI Surges 30% in 3 Months: How Should You Play the Stock?Read
2025-09-12
17:36
JNJ Seeks EU Approval for Oral Psoriasis Drug IcotrokinraRead
2025-09-08
12:52
CorMedix Inc (NASDAQ:CRMD) Embodies a Proven Growth Investing StrategyRead
2025-09-03
16:02
Cytokinetics Gains on Positive Late-Stage Cardiomyopathy Study ResultsRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of CorMedix Inc.

4.8.1. Institutions holding CorMedix Inc

Institutions are holding 46.782% of the shares of CorMedix Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31BlackRock Inc6.33330.000647259751580783.4606
2025-06-30Vanguard Group Inc5.79670.0009432554567899418.6202
2025-06-30Marshall Wace Asset Management Ltd3.45750.0358257997623494511019.1741
2025-03-31State Street Corp2.06260.00041539123859755.9165
2025-03-31Geode Capital Management, LLC1.92030.00071432919400992.879
2025-06-30Alyeska Investment Group, L.P.1.00510.03267500007500000
2025-06-30Anson Funds Management LP0.97161.28587250007250000
2025-06-30Trexquant Investment LP0.94870.0984707959572472422.5291
2025-03-31Morgan Stanley - Brokerage Accounts0.94310.000370374030489176.4427
2025-03-31UBS Group AG0.80750.000760253422266658.6167
2025-06-30Palisades Investment Partners, LLC0.75383.029656252720355756.7059
2025-03-31Northern Trust Corp0.69220.000551651749520.968
2025-06-30Oberweis Asset Management Inc0.650.2648500000
2025-06-30Kennedy Capital Management Inc0.64350.1414801787594718.788
2025-03-31Millennium Management LLC0.49730.0012371126192992108.3409
2025-03-31Susquehanna International Group, LLP0.4320.00033223502956231106.0837
2025-06-30Two Sigma Investments LLC0.42480.00693169632890131034.0358
2025-06-30New York State Common Retirement Fund0.39860.004929746314370093.4555
2025-06-30Squarepoint Ops LLC0.38970.0037290832224412337.8681
2025-03-31Amvescap Plc.0.38740.00032891102644071070.3437
Total 29.51574.904622024837+7582229+34.4%

4.9.2. Funds holding CorMedix Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-07-31Vanguard Total Stock Mkt Idx Inv3.13750.00142341249-51922-2.1696
2025-07-31iShares Russell 2000 ETF2.04560.02941526429-28980-1.8632
2025-07-31Vanguard Institutional Extnd Mkt Idx Tr0.97960.0106730984-320993-30.5133
2025-05-31Fidelity Small Cap Index0.82460.03615332-442-0.0718
2025-06-30CREF Stock R30.79630.005659421026189078.8066
2025-06-30Nuveen Quant Small Cap Equity R60.7780.212358052010442021.9324
2025-07-31iShares Russell 2000 Growth ETF0.76550.05757119300
2025-03-31Oberweis Micro-Cap Growth0.650.50264850004850000
2025-03-31Oberweis Micro-Cap0.650.5034850004850000
2025-07-31iShares Biotechnology ETF0.54510.087340675534790.8627
2025-07-31State St Russell Sm/Mid Cp® Indx SL Cl I0.53280.01063976093720010.3216
2025-06-30Kennedy Micro Cap0.50710.83073784345883718.4097
2025-06-30Fidelity Extended Market Index0.48920.01153650453333610.0498
2025-07-31Vanguard Russell 2000 ETF0.40990.0284305905-21398-6.5377
2025-06-30Palisades Small Cap Core0.3722.568727760013500094.6704
2025-07-31Swedbank Robur Healthcare A0.3350.196725000000
2025-07-31State St Russell Sm Cap® Indx SL Cl I0.29050.027921680000
2025-07-31SPDR® S&P Pharmaceuticals ETF0.22251.305416600300
2025-07-31Schwab Small Cap Index0.22070.029416470828691.7727
2025-06-30Vanguard US Momentum Factor ETF0.21340.175615926200
Total 14.76536.624111018038+1183296+10.7%

5.3. Insider Transactions

Insiders are holding 7.303% of the shares of CorMedix Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-11-14Elizabeth HurlburtSELL14002711.18
2024-10-31Erin MistryBUY15009.99
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets252,599,103
Total Liabilities31,968,916
Total Stockholder Equity220,630,187
 As reported
Total Liabilities 31,968,916
Total Stockholder Equity+ 220,630,187
Total Assets = 252,599,103

Assets

Total Assets252,599,103
Total Current Assets248,056,889
Long-term Assets4,542,214
Total Current Assets
Cash And Cash Equivalents 159,308,966
Short-term Investments 31,403
Net Receivables 42,912
Inventory 9,634,438
Other Current Assets 47,667,723
Total Current Assets  (as reported)248,056,889
Total Current Assets  (calculated)216,685,442
+/- 31,371,447
Long-term Assets
Property Plant Equipment 2,054,804
Intangible Assets 1,740,260
Long-term Assets Other 747,045
Long-term Assets  (as reported)4,542,214
Long-term Assets  (calculated)4,542,109
+/- 105

Liabilities & Shareholders' Equity

Total Current Liabilities31,710,843
Long-term Liabilities258,073
Total Stockholder Equity220,630,187
Total Current Liabilities
Short-term Debt 354
Accounts payable 5,815
Other Current Liabilities 31,704,673
Total Current Liabilities  (as reported)31,710,843
Total Current Liabilities  (calculated)31,710,843
+/-0
Long-term Liabilities
Capital Lease Obligations 435
Long-term Liabilities  (as reported)258,073
Long-term Liabilities  (calculated)435
+/- 257,638
Total Stockholder Equity
Common Stock74,621
Retained Earnings -299,158,154
Other Stockholders Equity 520,233,354
Total Stockholder Equity (as reported)220,630,187
Total Stockholder Equity (calculated)221,149,821
+/- 519,634
Other
Capital Stock75
Cash and Short Term Investments 190,711,816
Common Stock Shares Outstanding 71,919
Liabilities and Stockholders Equity 252,599,103
Net Debt -158,873,721
Net Invested Capital 220,630
Net Working Capital 216,346
Property Plant and Equipment Gross 2,055
Short Long Term Debt Total 435



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312007-12-31
> Total Assets 
4,113
1,620
0
0
0
2,226
12,070
10,991
9,733
8,848
6,819
4,949
3,031
2,556
2,035
1,036
1,257
1,153
968
395
1,037
2,968
9,761
8,256
6,845
5,098
9,752
38,796
39,307
37,102
33,610
31,213
28,840
21,906
14,933
21,156
13,929
13,454
9,609
5,927
8,049
18,826
27,308
27,559
33,717
29,476
27,400
24,237
40,023
49,308
84,259
80,857
75,389
68,946
64,934
67,748
62,077
62,038
59,234
57,033
91,429
82,060
68,024
57,731
77,586
118,846
149,583
252,599,103
252,599,103149,583118,84677,58657,73168,02482,06091,42957,03359,23462,03862,07767,74864,93468,94675,38980,85784,25949,30840,02324,23727,40029,47633,71727,55927,30818,8268,0495,9279,60913,45413,92921,15614,93321,90628,84031,21333,61037,10239,30738,7969,7525,0986,8458,2569,7612,9681,0373959681,1531,2571,0362,0352,5563,0314,9496,8198,8489,73310,99112,0702,2260001,6204,113
   > Total Current Assets 
0
0
0
0
0
1,683
12,016
10,952
9,694
8,812
6,786
4,918
3,003
2,531
2,012
1,000
1,238
1,135
950
378
1,020
2,916
9,714
8,188
6,785
5,038
9,686
38,746
39,261
37,059
33,570
31,176
28,760
21,832
14,865
21,094
13,853
13,268
9,404
5,741
7,870
18,665
27,142
27,413
33,583
29,349
27,281
24,134
38,865
48,182
83,057
79,691
72,991
66,469
62,503
65,359
59,664
59,551
56,781
54,625
89,062
79,450
63,410
53,194
73,154
114,575
144,862
248,056,889
248,056,889144,862114,57573,15453,19463,41079,45089,06254,62556,78159,55159,66465,35962,50366,46972,99179,69183,05748,18238,86524,13427,28129,34933,58327,41327,14218,6657,8705,7419,40413,26813,85321,09414,86521,83228,76031,17633,57037,05939,26138,7469,6865,0386,7858,1889,7142,9161,0203789501,1351,2381,0002,0122,5313,0034,9186,7868,8129,69410,95212,0161,68300000
       Cash And Cash Equivalents 
0
1,380
0
0
0
1,505
11,725
10,586
9,522
8,284
6,564
4,738
2,890
1,985
1,855
894
992
835
693
158
483
2,374
9,189
7,652
5,920
4,340
8,799
24,111
14,247
11,817
13,185
12,021
9,827
8,064
6,819
7,937
5,213
10,380
8,162
4,702
6,444
17,624
18,257
14,733
20,145
16,525
12,205
16,494
34,365
42,097
76,215
73,093
66,316
53,551
45,389
48,930
43,254
43,375
25,497
19,889
53,314
43,720
35,256
28,541
35,286
40,651
66,286
159,308,966
159,308,96666,28640,65135,28628,54135,25643,72053,31419,88925,49743,37543,25448,93045,38953,55166,31673,09376,21542,09734,36516,49412,20516,52520,14514,73318,25717,6246,4444,7028,16210,3805,2137,9376,8198,0649,82712,02113,18511,81714,24724,1118,7994,3405,9207,6529,1892,3744831586938359928941,8551,9852,8904,7386,5648,2849,52210,58611,7251,5050001,3800
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
220
221
221
0
0
0
132
13,377
23,605
23,568
17,044
16,591
16,827
12,101
6,951
10,884
6,796
1,604
1,604
172
172
0
7,945
11,825
12,294
11,984
10,983
5,948
2,675
4,444
4,957
5,159
5,653
12,149
16,298
15,693
15,746
15,644
30,332
32,701
33,273
32,388
23,371
17,070
10,744
11,037
11,217
31,403
31,40311,21711,03710,74417,07023,37132,38833,27332,70130,33215,64415,74615,69316,29812,1495,6535,1594,9574,4442,6755,94810,98311,98412,29411,8257,94501721721,6041,6046,79610,8846,95112,10116,82716,59117,04423,56823,60513,37713200022122122000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
494
494
0
0
0
0
0
0
2
14
55
46
80
69
113
125
316
345
6
22
12
76
154
89
64
9
3
302
11
34
-172
4
0
7
11
6
3
44
3
0
45
3
0
0
0
0
0
0
0
0
206
17,387
51,654
54,611
42,912
42,91254,61151,65417,3872060000000034503443611704-17234113023964891547612226345316125113698046551420000004944940000000000000
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
271
80
64
278
677
463
461
715
699
377
334
158
118
167
95
313
299
594
579
673
341
429
420
403
381
338
295
278
201
144
85
73
49
3
3
2
0
0
0
0
0
2,106
2,320
4,012
6,649
7,600
7,488
9,634,438
9,634,4387,4887,6006,6494,0122,3202,1060000023349738514420127829533838140342042934167357959429931395167118158334377699715461463677278648027100000000000000000000
   > Long-term Assets 
0
0
0
0
0
542
53
39
39
36
33
31
28
25
23
37
20
18
17
17
16
52
47
68
60
60
65
50
46
43
40
37
81
75
68
62
76
186
205
186
178
161
166
147
135
127
119
103
1,157
1,126
1,202
1,167
2,399
2,477
2,430
2,389
2,413
2,487
2,452
2,408
2,367
2,610
4,614
4,536
4,432
4,270
4,721
4,542,214
4,542,2144,7214,2704,4324,5364,6142,6102,3672,4082,4522,4872,4132,3892,4302,4772,3991,1671,2021,1261,1571031191271351471661611781862051867662687581374043465065606068475216171718203723252831333639395354200000
       Property Plant Equipment 
44
34
0
0
0
24
28
25
26
22
19
18
15
12
10
8
6
5
4
4
3
36
34
54
47
41
47
45
41
38
35
32
76
70
63
57
71
186
205
186
178
161
166
147
135
127
119
103
1,157
1,126
1,099
1,064
2,296
2,374
2,328
2,286
2,310
2,385
2,350
2,306
2,264
2,507
2,510
2,484
2,431
2,321
2,182
2,054,804
2,054,8042,1822,3212,4312,4842,5102,5072,2642,3062,3502,3852,3102,2862,3282,3742,2961,0641,0991,1261,15710311912713514716616117818620518671576370763235384145474147543436344568101215181922262528240003444
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,000
1,948
1,896
1,844
1,792
1,740,260
1,740,2601,7921,8441,8961,9482,00000000000000000000000000000000000000000000000000000000000000000
       Long-term Assets Other 
0
0
0
0
0
507
0
0
0
0
0
13
13
13
13
15
13
13
13
13
13
16
13
13
13
18
18
5
5
5
5
5
5
5
5
5
5
0
0
0
0
0
166
147
135
127
119
0
1,042
1,015
102
102
102
102
102
102
102
102
-30,302,058
102
103
0
2,101,838
2,050,530
105
105
747
747,045
747,0457471051052,050,5302,101,8380103102-30,302,0581021021021021021021021021,0151,0420119127135147166000005555555555181813131316131313131315131313130000050700000
> Total Liabilities 
0
13,647
0
0
0
16,935
1,421
1,171
956
1,592
1,459
1,715
2,293
1,319
1,612
1,180
1,374
1,629
2,244
2,589
3,945
6,990
13,490
9,856
1,267
1,463
2,156
1,945
2,915
3,090
3,090
3,142
5,061
4,092
3,890
5,790
4,252
6,261
8,768
12,405
17,546
13,892
10,766
11,084
5,010
5,830
5,806
5,716
5,553
5,085
3,944
3,988
6,045
6,148
5,064
6,009
5,765
6,979
5,306
7,982
8,227
11,918
10,011
11,547
18,874
34,189
34,695
31,968,916
31,968,91634,69534,18918,87411,54710,01111,9188,2277,9825,3066,9795,7656,0095,0646,1486,0453,9883,9445,0855,5535,7165,8065,8305,01011,08410,76613,89217,54612,4058,7686,2614,2525,7903,8904,0925,0613,1423,0903,0902,9151,9452,1561,4631,2679,85613,4906,9903,9452,5892,2441,6291,3741,1801,6121,3192,2931,7151,4591,5929561,1711,42116,93500013,6470
   > Total Current Liabilities 
1,212
13,647
0
0
0
16,935
1,421
1,152
938
1,576
1,443
1,700
2,278
1,305
1,598
1,166
1,362
1,616
2,233
2,579
3,937
1,674
1,122
1,181
1,227
1,425
2,120
1,912
2,882
3,061
3,064
3,118
5,039
4,092
3,890
5,790
4,252
6,261
8,768
12,405
17,546
7,766
4,335
4,346
5,007
5,827
5,804
5,714
4,601
4,162
3,049
3,123
5,211
5,345
4,294
5,272
5,062
6,311
4,675
7,387
7,671
11,401
9,534
11,111
18,481
33,840
34,391
31,710,843
31,710,84334,39133,84018,48111,1119,53411,4017,6717,3874,6756,3115,0625,2724,2945,3455,2113,1233,0494,1624,6015,7145,8045,8275,0074,3464,3357,76617,54612,4058,7686,2614,2525,7903,8904,0925,0393,1183,0643,0612,8821,9122,1201,4251,2271,1811,1221,6743,9372,5792,2331,6161,3621,1661,5981,3052,2781,7001,4431,5769381,1521,42116,93500013,6471,212
       Short-term Debt 
0
0
0
0
0
13,765
0
0
0
0
0
0
0
0
0
0
126
254
599
696
1,535
0
0
0
0
0
0
66
70
67
71
1
3
2
13
2,042
0
0
0
0
0
0
2
0
0
2
0
0
196
109
112
116
118
121
124
127
262
135
139
285
293
301
310
318
327
336
345
354
3543453363273183103012932851391352621271241211181161121091960020020000002,04213231716770660000001,535696599254126000000000013,76500000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,880
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000020000001,88000000000000000000000000000000000000
       Accounts payable 
1,212
822
0
0
0
550
1,046
804
517
1,139
1,294
1,437
990
913
1,425
994
918
929
1,312
1,489
970
940
1,027
849
740
893
1,429
1,142
1,425
1,709
1,581
1,109
1,758
1,645
1,726
1,766
1,408
1,808
3,660
7,309
7,882
2,589
1,462
906
1,055
1,024
1,333
1,386
1,986
1,128
1,500
943
1,107
2,210
1,740
2,496
1,767
2,202
1,447
2,901
2,386
4,280
2,826
3,345
1,344
1,720
1,933
5,815
5,8151,9331,7201,3443,3452,8264,2802,3862,9011,4472,2021,7672,4961,7402,2101,1079431,5001,1281,9861,3861,3331,0241,0559061,4622,5897,8827,3093,6601,8081,4081,7661,7261,6451,7581,1091,5811,7091,4251,1421,4298937408491,0279409701,4891,3129299189941,4259139901,4371,2941,1395178041,0465500008221,212
       Other Current Liabilities 
0
1,172
0
0
0
2,620
375
348
421
436
149
263
1,288
392
174
173
318
434
322
394
1,432
734
95
332
478
522
682
695
1,380
1,154
1,276
1,876
3,146
2,341
2,050
3,922
2,758
4,364
5,091
5,080
9,651
5,166
2,864
3,434
3,947
4,798
4,471
4,328
2,419
2,924
1,437
2,064
3,986
3,014
2,430
2,649
3,032
3,974
3,089
4,202
4,992
6,820
6,399
7,448
16,810
31,784
32,113
31,704,673
31,704,67332,11331,78416,8107,4486,3996,8204,9924,2023,0893,9743,0322,6492,4303,0143,9862,0641,4372,9242,4194,3284,4714,7983,9473,4342,8645,1669,6515,0805,0914,3642,7583,9222,0502,3413,1461,8761,2761,1541,380695682522478332957341,4323943224343181731743921,2882631494364213483752,6200001,1720
   > Long-term Liabilities 
0
0
0
0
0
0
0
19
18
17
16
16
15
14
14
13
13
12
11
10
8
5,316
12,368
8,676
40
38
36
33
33
29
27
24
22
0
0
0
0
0
0
0
0
6,125
6,431
6,738
3
3
2
2
952
924
894
864
834
802
770
737
703
668
631
594
556
517
477
435
393
349
304
258,073
258,07330434939343547751755659463166870373777080283486489492495222336,7386,4316,125000000002224272933333638408,67612,3685,3168101112131314141516161718190000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,125
6,427
6,734
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000006,7346,4276,12500000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
-13,765
0
0
0
0
0
0
0
0
0
0
-126
-254
-599
-696
-1,535
0
0
0
0
0
0
-66
-70
-67
-71
-1
-3
-2
-13
-2,042
0
0
0
0
0
0
2
3
3
1
2
2
854
924
894
864
834
802
770
737
572
668
631
452
410
366
322
276
230
181
132
81
81132181230276322366410452631668572737770802834864894924854221332000000-2,042-13-2-3-1-71-67-70-66000000-1,535-696-599-254-1260000000000-13,76500000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
3
3
3
2
2
952
924
894
864
834
802
770
737
703
0
631
594
0
0
0
0
0
0
0
0
000000005946310703737770802834864894924952223334000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
16
15
14
14
13
13
12
11
10
8
5,316
12,368
8,676
40
38
36
33
33
29
27
24
22
29
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000292224272933333638408,67612,3685,316810111213131414151600000000000
> Total Stockholder Equity
0
0
0
0
0
-14,709
10,649
9,820
8,777
7,255
5,360
3,234
738
1,237
423
-143
-117
-475
-1,276
-2,194
-2,909
-4,022
-3,729
-1,601
5,578
3,634
7,596
36,851
36,392
34,011
30,519
28,071
23,779
17,815
11,043
15,366
9,676
-152,175
841
-6,478
-9,498
-178,988
16,542
-184,852
28,708
-195,421
21,593
18,521
34,469
-217,449
80,315
76,870
69,344
-245,659
59,869
61,739
56,312
-275,361
-285,928
-297,202
83,202
70,142
58,013
46,184
58,712
84,657
114,888
220,630,187
220,630,187114,88884,65758,71246,18458,01370,14283,202-297,202-285,928-275,36156,31261,73959,869-245,65969,34476,87080,315-217,44934,46918,52121,593-195,42128,708-184,85216,542-178,988-9,498-6,478841-152,1759,67615,36611,04317,81523,77928,07130,51934,01136,39236,8517,5963,6345,578-1,601-3,729-4,022-2,909-2,194-1,276-475-117-1434231,2377383,2345,3607,2558,7779,82010,649-14,70900000
   Retained Earnings -299,158,154-318,986-339,630-353,094-350,318-336,166-321,700-306,946-297,202-285,928-275,361-267,152-260,298-252,693-245,659-237,868-229,299-224,666-217,449-211,362-204,761-200,979-195,421-190,117-184,852-184,156-178,988-181,136-170,900-162,342-152,175-141,864-131,908-126,762-119,165-112,636-103,510-98,623-94,392-90,525-85,837-81,702-76,204-73,990-68,955-72,491-55,751-52,464-49,772-47,811-46,373-45,185-44,482-43,858-42,948-43,288-40,688-38,211-36,236-34,733-33,341-32,168-25,33100000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
-26
0
0
0
-38
-38
0
0
0
0
0
0
-57
0
0
0
-9
-11
-1
117
99
102
93
100
62
93
90
83
81
90
97
95
98
97
97
91
97
95
104
102
97
91
106
100
102
99
99
96
87
50
40
46
83
101
91
84
94
83
86
89
91
85
79
7985918986839484911018346405087969999102100106919710210495979197979895979081839093621009310299117-1-11-9000-57000000-38-38000-2600000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
43,912
44,015
44,173
44,269
44,327
45,057
45,887
46,652
47,694
49,539
51,720
68,750
67,332
79,427
79,716
89,168
122,560
126,781
128,305
129,012
131,452
136,291
136,857
137,674
147,117
151,384
159,198
163,004
164,239
171,449
183,717
200,579
201,199
218,697
218,944
222,455
223,151
245,700
261,536
304,844
306,031
307,079
308,332
312,474
321,956
323,377
0
339,710
346,116
0
0
0
0
0
0
0
0
00000000346,116339,7100323,377321,956312,474308,332307,079306,031304,844261,536245,700223,151222,455218,944218,697201,199200,579183,717171,449164,239163,004159,198151,384147,117137,674136,857136,291131,452129,012128,305126,781122,56089,16879,71679,42767,33268,75051,72049,53947,69446,65245,88745,05744,32744,26944,17344,01543,91200000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000-1-1



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue43,472
Cost of Revenue-3,191
Gross Profit40,28240,282
 
Operating Income (+$)
Gross Profit40,282
Operating Expense-62,638
Operating Income-22,356-22,356
 
Operating Expense (+$)
Research Development3,942
Selling General Administrative29,959
Selling And Marketing Expenses28,737
Operating Expense62,63862,638
 
Net Interest Income (+$)
Interest Income2,579
Interest Expense-36
Other Finance Cost-0
Net Interest Income2,542
 
Pretax Income (+$)
Operating Income-22,356
Net Interest Income2,542
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-19,325-25,388
EBIT - interestExpense = -19,325
-19,325
-17,894
Interest Expense36
Earnings Before Interest and Taxes (EBIT)-19,288-19,288
Earnings Before Interest and Taxes (EBITDA)-18,831
 
After tax Income (+$)
Income Before Tax-19,325
Tax Provision--1,395
Net Income From Continuing Ops-17,930-17,930
Net Income-17,930
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses65,829
Total Other Income/Expenses Net3,032-2,542
 

Technical Analysis of Cormedix
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cormedix. The general trend of Cormedix is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cormedix's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Cormedix Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of CorMedix Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 14.96 < 17.43.

The bearish price targets are: 12.48 > 11.58 > 9.605.

Know someone who trades $CRMD? Share this with them.👇

CorMedix Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of CorMedix Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

CorMedix Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of CorMedix Inc.

CorMedix Inc Daily Moving Average Convergence/Divergence (MACD) ChartCorMedix Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of CorMedix Inc. The current adx is .

CorMedix Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of CorMedix Inc.

CorMedix Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of CorMedix Inc.

CorMedix Inc Daily Relative Strength Index (RSI) ChartCorMedix Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of CorMedix Inc.

CorMedix Inc Daily Stochastic Oscillator ChartCorMedix Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of CorMedix Inc.

CorMedix Inc Daily Commodity Channel Index (CCI) ChartCorMedix Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of CorMedix Inc.

CorMedix Inc Daily Chande Momentum Oscillator (CMO) ChartCorMedix Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of CorMedix Inc.

CorMedix Inc Daily Williams %R ChartCorMedix Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of CorMedix Inc.

CorMedix Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of CorMedix Inc.

CorMedix Inc Daily Average True Range (ATR) ChartCorMedix Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of CorMedix Inc.

CorMedix Inc Daily On-Balance Volume (OBV) ChartCorMedix Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of CorMedix Inc.

CorMedix Inc Daily Money Flow Index (MFI) ChartCorMedix Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for CorMedix Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-05-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-06ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-14MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-07-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-08-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-08-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-28MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-02STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-09-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.

6.3. Candlestick Patterns

CorMedix Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of CorMedix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose12.590
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Cormedix with someone you think should read this too:
  • Are you bullish or bearish on Cormedix? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cormedix? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about CorMedix Inc

I send you an email if I find something interesting about CorMedix Inc.


Comments

How you think about this?

Leave a comment

Stay informed about CorMedix Inc.

Receive notifications about CorMedix Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.